当前位置:
X-MOL 学术
›
Nat. Biomed. Eng.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Towards safe therapy for immunodeficiency
Nature Biomedical Engineering ( IF 26.8 ) Pub Date : 2017-12-12 , DOI: 10.1038/s41551-017-0174-x Shengdar Q. Tsai
Nature Biomedical Engineering ( IF 26.8 ) Pub Date : 2017-12-12 , DOI: 10.1038/s41551-017-0174-x Shengdar Q. Tsai
Towards safe therapy for immunodeficiency
中文翻译:
寻求针对免疫缺陷的安全疗法
寻求针对免疫缺陷的安全疗法
更新日期:2017-12-12
Towards safe therapy for immunodeficiency, Published online: 12 December 2017; doi:10.1038/s41551-017-0174-x
A humanized mouse model of X-linked severe combined immunodeficiency suggests that the safety of correcting the human IL2RG gene in haematopoietic stem cells depends on both gene-correction frequency and the conditioning regimen used before cell transplantation.中文翻译:
寻求针对免疫缺陷的安全疗法
寻求针对免疫缺陷的安全疗法
迈向免疫缺陷的安全疗法,在线发布:2017年12月12日;doi:10.1038 / s41551-017-0174-x
X连锁严重联合免疫缺陷的人源化小鼠模型提示,在造血干细胞中纠正人IL2RG基因的安全性取决于基因纠正频率和细胞移植前使用的条件疗法。